A detailed history of Advisory Services Network, LLC transactions in Organon & Co. stock. As of the latest transaction made, Advisory Services Network, LLC holds 31,057 shares of OGN stock, worth $466,786. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,057
Previous 31,057 -0.0%
Holding current value
$466,786
Previous $642,000 7.48%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $88,244 - $111,051
5,057 Added 19.45%
31,057 $642,000
Q1 2024

May 06, 2024

SELL
$13.78 - $18.8 $440,436 - $600,885
-31,962 Reduced 55.14%
26,000 $488,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $24,133 - $38,173
2,204 Added 3.95%
57,962 $835,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $692,466 - $992,159
41,740 Added 297.76%
55,758 $967,000
Q2 2023

Aug 09, 2023

SELL
$19.27 - $24.63 $123,462 - $157,804
-6,407 Reduced 31.37%
14,018 $291,000
Q1 2023

May 17, 2023

BUY
$21.42 - $32.08 $201,647 - $302,001
9,414 Added 85.5%
20,425 $480,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $145,407 - $178,469
-6,238 Reduced 36.16%
11,011 $307,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $94,816 - $138,781
-4,052 Reduced 19.02%
17,249 $403,000
Q2 2022

Aug 02, 2022

BUY
$31.66 - $38.9 $13,993 - $17,193
442 Added 2.12%
21,301 $719,000
Q1 2022

May 23, 2022

BUY
$30.45 - $39.36 $265,493 - $343,179
8,719 Added 71.82%
20,859 $728,000
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $348,053 - $450,758
12,140 New
12,140 $370,000
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $181,800 - $226,314
-6,350 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $180,657 - $241,300
6,350 New
6,350 $192,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.